Gottlieb, Hargan, Owcharenko Join Trump's HHS Transition Team

Abstract

December 01, 2016 Scott Gottlieb, former FDA deputy commissioner and resident fellow at the American Enterprise Institute, who has advocated for relaxation of FDA's limits of off-label uses of drugs and has said FDA policies are partly to blame for high drug prices, was named to President-elect Donald Trump's HHS Agency Landing Team Thursday (Dec. 1).